Table 3 Cox regression analysis of factors associated with LTFU among adult patients on ART therapy at Karamara General Hospital, September 2007 to September 2014, Somali region, Jigjiga town, Eastern Ethiopia, 2015
Variables | Loss to Follow Up | AHR | P- Value | |
|---|---|---|---|---|
Yes | No | (95% CI) | ||
Sex | ||||
 Male | 107 (34.2) | 498 (65.8) | 2.1 (1.3–3.4) | 0.034* |
 Female | 106 (24.7) | 728 (75.3) | 1 |  |
Next appointment recorded properly | ||||
 Yes | 190 (17.4) | 902 (82.6) | 1 | 0.000* |
 No | 23 (6.6) | 324 (93.4) | 1.2 (1.12–1.36) |  |
History of TB treatment | ||||
 Yes | 71 (19.4) | 296 (80.6) | 1.2 (0.08–1.38) |  |
 No | 142 (13.2) | 930 (86.8) | 1 | 0.561 |
WHO Stagea | ||||
 I | 38 (11.6) | 290 (88.4) | 1 |  |
 II | 29 (12.7) | 199 (87.3) | 0.4 (0.34–2.34) | 0.341 |
 III | 111 (16.6) | 559 (83.4) | 0.8 (0.40–1.17) | 0.123 |
 IV | 35 (16.4) | 178 (83.6) | 0.6 (0.28–1.43) | 0.112 |
Functional statusb | ||||
 Functional | 81 (10.0) | 730 (90.0) | 1 |  |
 Ambulatory | 96 (19.6) | 392 (80.4) | 0.73 (0.44–1.2) | 0.2213 |
 Bed ridden | 36 (25.7) | 104 (74.3) | 1.31 (0.86–1.9) | 0.2364 |
CD4 Count | ||||
 = < 200 | 152 (16.3) | 783 (83.7) | 0.7 (0.5–1.0) | 0.117 |
 201–250 | 21 (10.8) | 174 (89.2) | 0.6 (0.4–1.8) | 0.712 |
 251–300 | 16 (8.2) | 180 (91.8) | 0.7 (0.6–1.0) | 0.371 |
 301–350 | 10 (8.9) | 103 (91.1) | 0.9 (1.1–1.8) | 0.682 |
 > = 351 | 14 (12.4) | 99 (87.6) | 1 |  |
Disclosure status | ||||
 Disclosed to any one | 76 (7.0) | 1005 (93.0) | 1 |  |
 Not disclosed to any one | 137 (38.3) | 221 (61.7) | 2.8 (2.22–5.23) | 0.034* |